You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Claims for Patent: 4,775,529

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 4,775,529

Title:	Steroid lotion
Abstract:	An improved lotion formulation for the topical administration of corticosteroids in a hydro-alcoholic base containing propylene glycol.
Inventor(s):	Sequeira; Joel A. (New York, NY), Munayyer; Farah J. (West Caldwell, NJ), Galeos; Rebecca (Bloomfield, NJ)
Assignee:	Schering Corporation (Kenilworth, NJ)
Application Number:	07/053,172
Patent Claims:	1. A topical lotion for the treatment of inflammation which comprises an amount effect to treat said inflammation of a dermatologically acceptable anti-inflammatory corticosteroid in a hydro-alcoholic base consisting essentially of: 15 to 50% by weight of propylene glycol; 20 to 40% by weight of isopropyl alcohol; 20 to 60% by weight water; 0.1 to 3.0% by weight of a thickening agent, and sufficient buffer to maintain the pH of the composition within the range of 3.0 to 6.0. 2. The lotion of claim 1 wherein the corticosteroid comprises 0.01 to 1.0% by weight of the composition. 3. The lotion of claim 2 wherein the corticosteroid comprises 0.02 to 0.2% by weight of the composition. 4. The lotion of claim 1 wherein the corticosteroid is betamethasone 17,21-dipropionate. 5. The lotion of claim 4 wherein the betamethasone 17,21-dipropionate is present in an amount of 0.064% by weight. 6. The lotion of claim 5 consisting essentially of: 7. The lotion of claim 1 wherein the corticosteroid is alclometasone dipropionate. 8. The lotion of claim 7 consisting essentially of: 9. The lotion of claim 1 wherein the corticosteroid is mometasone furoate. 10. The lotion of claim 9 consisting essentially of: 11. The lotion of claim 1 wherein the thickening agent is an acrylic acid polymer. 12. The lotion of claim 1 wherein the thickening agent is hydroxypropyl cellulose. 13. The method of treating inflammation which comprises applying to the skin a topical lotion formulation comprising an amount effective to treat said inflammation of a dermatologically acceptable anti-inflamatory corticosteroid in a hydro-alcoholic base consisting essentially of: 15 to 50% by weight of propylene glycol; 20 to 40% by weight of isopropyl alcohol; 20to 60% by weight water; 0.1 to 3.0% by weight of a thickening agent, and sufficient buffer to maintain the pH of the composition within the range of 3.0 to 6.0. 14. The method of claim 13 wherein the corticosteroid comprises 0.01 to 1.0% by weight of the composition. 15. The method of claim 14 wherein the corticosteroid comprises 0.02 to 0.2% by weight of the composition. 16. The method of claim 13 wherein the corticosteroid is betamethasone 17,21-dipropionate. 17. The method of claim 13 wherein the corticosteroid is alclometasone dipropionate. 18. The method of claim 13 wherein the corticosteroid is mometasone furoate.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.